Baylor Genetics

Profile narrative

Baylor Genetics is a clinical laboratory that specializes in genetic testing and diagnostic services. It provides a variety of tests, including prenatal, oncology, cardiology, and neurology panels, to support patient care. Healthcare providers, patients, and medical institutions across the United States utilize its services. The laboratory analyzes DNA specimens to detect genetic variations linked to disease risk, diagnosis, and treatment decisions. Results are delivered in clinical reports that guide physicians in personalized medicine approaches. The organization processes a high volume of specimens each year, reflecting its role as a major provider of genetic diagnostics. Its workflow involves sample receipt, nucleic acid extraction, sequencing or genotyping, data analysis, and report generation. In June 2026, Baylor Genetics disclosed a cybersecurity incident where an unauthorized party accessed part of its IT environment. The breach exposed personal and medical information such as names, dates of birth, laboratory test results, health insurance details, and, for some individuals, Social Security numbers. The incident underscored the sensitivity of the data the laboratory routinely handles in its testing operations.

Baylor Genetics focuses exclusively on clinical genetics, distinguishing it from laboratories that perform routine chemistry or hematology testing. The organization holds Clinical Laboratory Improvement Amendments (CLIA) certification and is accredited by the College of American Pathologists (CAP). Its expertise includes interpreting complex genetic variants and providing actionable information for physicians and patients. The laboratory serves as a reference center for difficult‑to‑diagnose cases, often receiving specimens from other providers seeking specialized analysis. Details about its ownership structure or any parent‑subsidiary relationships are not specified in the available sources.

Incidents

1 incident linked to this organisation.